REAL-WORLD CARDIAC SAFETY OF ANTI-HER2 THERAPIES IN ELDERLY PATIENTS WITH HER2+/HR-METASTATIC BREAST CANCER: A RETROSPECTIVE COHORT STUDY USING SEER-MEDICARE DATA 2012-2016

被引：0
|
作者：
Ou, Z. [1 ]
Nohria, A. [2 ]
Spring, L. M. [3 ]
Seeger, J. D. [4 ]
Doucette, J. [5 ]
Murimi-Worstell, I. B. [5 ]
机构：
[1] MCPHS Univ, Belmont, MA USA
[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA
[4] Optum, Boston, MA USA
[5] MCPHS Univ, Boston, MA USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
SA33
引用
收藏
页码：S610 / S610
页数：1
相关论文
共 50 条
  • [21] Effectiveness and safety of pyrotinib-based therapy in patients with HER2-positive metastatic breast cancer: A real-world retrospective study
    Li, Chao
    Bian, Xiaoli
    Liu, Zhaoyun
    Wang, Xinzhao
    Song, Xiang
    Zhao, Wei
    Liu, Yansong
    Yu, Zhiyong
    CANCER MEDICINE, 2021, 10 (23): : 8352 - 8364
  • [22] The Effectiveness of Lapatinib in HER2-Positive Metastatic Breast Cancer Patients Pretreated With Multiline Anti-HER2 Treatment: A Retrospective Study in China
    Wang, Xinzhao
    Wang, Lin
    Yu, Qian
    Liu, Zhaoyun
    Li, Chao
    Wang, Fukai
    Yu, Zhiyong
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [23] Impact of HER2-Low Status in Metastatic Gastric Cancer: A Real-World Retrospective Cohort Study
    Unal, Olcun Umit
    Akay, Seval
    Gul, Gurkan
    Keser, Murat
    Ozamrak, Birsen Gizem
    Solakoglu Kahraman, Dudu
    Erdogan, Mihriban
    ONCOLOGY, 2024, 102 (10) : 889 - 896
  • [24] Real-world impact of dual anti-HER2 antibodies on cardiac function in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Bao, Kelvin K. H.
    Chan, Jeffrey C. H.
    Chan, Jocelyn G.
    Sutanto, Leone
    Cheung, Ka Man
    Yiu, Harry H. Y.
    BREAST, 2024, 73
  • [25] First-Line Efficacy of Anti-HER2 Treatments in Previously Treated HER2-Positive Metastatic Breast Cancer Patients: A Retrospective Observational Study Investigating the Efficacy of Re-Exposure to Anti-HER2 Therapy for HER2-Positive Metastatic Breast Cancer Patients in Comparison with Naive Patients
    Waissengrin, Barliz
    Levin, Roni
    Wolf, Ido
    Shachar, Eliya
    Sonnenblick, Amir
    BREAST CARE, 2022, 17 (02) : 146 - 152
  • [26] Anti-HER2 therapy-associated cardiotoxicity in breast cancer patients: analysis of real-world data from a UK cancer centre
    Efthymiadis, Agathoklis
    Teoh, May
    CLINICAL MEDICINE, 2020, 20 : S20 - S20
  • [27] Treatment patterns and their impact on the outcome of patients with HR+/HER2+metastatic breast cancer in a large real-world cohort.
    Carausu, Marcela
    Carton, Matthieu
    Dieras, Veronique C.
    Petit, Thierry
    Lahaye, Severine Guiu
    Veyret, Corinne
    Goncalves, Anthony
    Augereau, Paule
    Ferrero, Jean-Marc
    Levy, Christelle
    Ung, Mony
    Desmoulins, Isabelle
    Debled, Marc
    Bachelot, Thomas
    Eymard, Jean-Christophe
    Pistilli, Barbara
    Frenel, Jean-Sebastien
    Chevrot, Michael
    Mailliez, Audrey
    Cabel, Luc
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [28] Treatment sequences and survival outcomes in advanced HR+HER2-breast cancer patients: a real-world cohort
    Almekinders, Cornelia A. M.
    Lin, Lishi
    Beijnen, Jos H.
    Sonke, Gabe S.
    Huitema, Alwin D. R.
    Dezentje, Vincent O.
    BREAST CANCER RESEARCH AND TREATMENT, 2025, 210 (01) : 115 - 124
  • [29] Abemaciclib for treating patients with HR+/HER2-metastatic breast cancer: a real-world study in France, Italy and Spain
    Blancas, Isabel
    Grosjean, Jessica
    Pedersini, Rebecca
    Buzzoni, Carlotta
    Sleilaty, Ghassan
    Molero, Alberto
    Tamma, Antonella
    Chouaki, Nadia
    Atienza, Manuel
    Emde, Anna
    Siddi, Sara
    Bayona, Rodrigo Sanchez
    Del Mastro, Lucia
    Fakhouri, Walid
    FUTURE ONCOLOGY, 2024, 20 (31) : 2371 - 2384
  • [30] Real-world treatment of patients with palbociclib for HR+/HER2-advanced/metastatic breast cancer: the Europe IRIS study
    Mycock, Katie
    Zhan, Lin
    Hart, Kieran
    Taylor-Stokes, Gavin
    Milligan, Gary
    Atkinson, Christian
    Mitra, Debanjali
    FUTURE ONCOLOGY, 2021, 18 (03) : 349 - 362
12345